Gloria R. Grice

U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole.

Major depressive disorder (MDD) remains a significant illness worldwide, yet antidepressant therapy often follows an empirical "trial-and-error" approach. Escitalopram, a selective serotonin reuptake inhibitor is approved for MDD and generalized anxiety disorders, while aripiprazole (ARI), an atypical antipsychotic, is...